Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gentamicin 0.3% / Hydrocortisone acetate 1% ear drops
1201010G0AAACAC
|
Hydrocortisone acetate (Ear) | Hydrocortisone acetate | Ear, Nose and Oropharynx | 14,985 |
|
Hydrocortisone 1.5% / Neomycin 0.5% ear/eye drops
1201010G0AAAAAA
|
Hydrocortisone acetate (Ear) | Hydrocortisone acetate | Ear, Nose and Oropharynx | No data available |
|
Hydrocortisone 1.5% / Neomycin 0.5% ear/eye ointment
1201010G0AAABAB
|
Hydrocortisone acetate (Ear) | Hydrocortisone acetate | Ear, Nose and Oropharynx | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.